Patients in a clinical trial will receive a placebo or remdesivir, which has shown promise in laboratory studies.
Published: February 6, 2020 at 11:50PM
from NYT Health https://ift.tt/2upNK5a
Patients in a clinical trial will receive a placebo or remdesivir, which has shown promise in laboratory studies.
Published: February 6, 2020 at 11:50PM
from NYT Health https://ift.tt/2upNK5a
We use cookies to improve your experience on our site. By using our site, you consent to cookies.
Manage your cookie preferences below:
Essential cookies enable basic functions and are necessary for the proper function of the website.
Google reCAPTCHA helps protect websites from spam and abuse by verifying user interactions through challenges.
Statistics cookies collect information anonymously. This information helps us understand how visitors use our website.
Google Analytics is a powerful tool that tracks and analyzes website traffic for informed marketing decisions.
Service URL: policies.google.com (opens in a new window)